Lim Kok Thay 4

Accession 0000905148-25-000224

CIK 0001752828other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 4:45 PM ET

Size

25.2 KB

Accession

0000905148-25-000224

Form 4

Period: 2025-01-24

10% Owner

Transactions

Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Other
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+535,274$1,108,017→ 5,682,649 total(indirect: By Dragasac Limited)
Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+652,981$1,351,671→ 6,335,630 total(indirect: By Dragasac Limited)
Other
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24+535,274→ 535,274 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24+652,981→ 652,981 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)

Holdings

10% Owner

Transactions

Other
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+535,274$1,108,017→ 5,682,649 total(indirect: By Dragasac Limited)
Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+652,981$1,351,671→ 6,335,630 total(indirect: By Dragasac Limited)
Other
Warrants (Right to Buy)
2025-01-24+535,274→ 535,274 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24+652,981→ 652,981 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)

Holdings

10% Owner

Transactions

Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+652,981$1,351,671→ 6,335,630 total(indirect: By Dragasac Limited)
Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Other
Warrants (Right to Buy)
2025-01-24+535,274→ 535,274 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24−652,981→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)
Exercise of In-Money
Class A Common Stock
2025-01-24$2.07/sh+535,274$1,108,017→ 5,682,649 total(indirect: By Dragasac Limited)
Other
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.49From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Exercise of In-Money
Warrants (Right to Buy)
2025-01-24−535,274→ 0 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2029-01-16→ Class A Common Stock (535,274 underlying)
Other
Warrants (Right to Buy)
2025-01-24+652,981→ 652,981 total(indirect: By Dragasac Limited)
Exercise: $2.07From: 2024-01-16Exp: 2030-03-16→ Class A Common Stock (652,981 underlying)

Holdings

Footnotes (3)

[F1]These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split").
[F2]These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein.
[F3]On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock.

Documents

1 file

Celularity Inc

CIK 0001752828

Entity typeother